NEW YORK, NY / ACCESSWIRE / April 24, 2024 / If you suffered a loss on your Anavex Life Sciences Corporation (NASDAQ:AVXL) investment and want to learn about a potential recovery under the federal ...

Currently, records show that 15.76 million of the company’s shares remain outstanding. The insiders hold 7.32% of outstanding ...

(Nasdaq: GILD) announced today its first quarter 2024 results of operations. "Gilead delivered another strong quarter of ...

Standard BioTools aims to shed 10% of jobs, make other cuts months after $1 billion merger that nearly doubled its workforce ...

Palisade Bio entered into a collaboration with Strand Life Sciences is aimed at advancing precision medicine for ulcerative ...

Vertex Pharmaceuticals' $4.9 billion purchase of Alpine Immune Sciences probably won't be the last acquisition of a company ...

Gilead Sciences is set to announce its Q1 earnings results on April 25th. Analysts predict a -$1.54 EPS and $6.35B in revenue ...

Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $18.0, with a high ...

The most recent trading session ended with Gilead Sciences (GILD) standing at $68.07, reflecting a -0.84% shift from the previouse trading day's closing. The stock's performance was ahead of the S&P ...

Palantir stock is slipping on Thursday even as PLTR traders learn of a new contract between the data company and Parexel.More ...